Search clinical trials for: motesanib diphosphate

Total 3735 results

Merck Sharp & Dohme LLC

Completed

A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

Type 2 Diabetes Mellitus (T2DM)
Merck Sharp & Dohme LLC

Completed

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

Type 2 Diabetes
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Leukemia

United States
Merck Sharp & Dohme LLC

Completed

MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)

Type 2 Diabetes Mellitus
Genzyme, a Sanofi Company

Completed

Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)

Leukemia, B-Cell, Chronic

Italy
Instituto Nacional de Ciencias Medicas y Nutricion...
Merck Sharp & Dohme LLC

Completed

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

Reactive Hypoglycemia

Mexico
Istituto di Ricerca Neuroftalmologia S.r.l.
University of Milan

Completed

The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma

Glaucoma
Endo Pharmaceuticals

Terminated

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Carcinoma in Situ | Transitional Cell Carcinoma | Non-muscle Invasive Bladder Cancer

United States
Deborah Yurgelun-Todd

Withdrawn

Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)

Traumatic Brain Injury | Substance Abuse | Substance Dependence
Daré Bioscience, Inc.

Completed

DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)

Bacterial Vaginosis

United States
National Cancer Institute (NCI)

Completed

Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Leukemia

United States
M.D. Anderson Cancer Center
Sanofi

Terminated

Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia

United States
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ain Shams University

Completed

Alveolar Ridge Preservation Using Different Bone Substitutes

Alveolar Ridge Enlargement

Egypt
Royal College of Surgeons in Ireland - Medical...
Bahrain Defence Force Hospital; Salmaniya Medical Complex

Completed

Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19

COVID-19 | SARS-CoV 2

Bahrain
Fundacion Clinic per a la Recerca Biomédica

Unknown

Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal (PROTEDI)

Prostheses Infection
Dong-A ST Co., Ltd.

Completed

Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

Healthy

Korea, Republic of
University of Aarhus
Ceramisys Ltd

Terminated

New Bone Grafting Technique in Paediatric Foot Surgery. Validation of Outcome Measures

Pes Planovalgus

Denmark
Washington University School of Medicine

Terminated

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)

Coronavirus Infection

United States
Zhejiang University
Hangzhou Cheetah Cell Therapeutics Co., Ltd

Recruiting

BCMA CAR-NK For Patients With RRMM

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory

China
University of Oslo

Terminated

Mandibular Furcation III Regeneration (FURC-III-REGEN) (FURC-III-REGEN)

Periodontal Diseases | Furcation Defects

Norway
Merck Sharp & Dohme LLC

Completed

Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

Diabetes Mellitus, Non-Insulin-Dependent
M.D. Anderson Cancer Center

Completed

Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Leukemia | AML | MDS | CML

United States
European Organisation for Research and Treatment...

Unknown

Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia

Leukemia

Belgium, Netherlands, Czech Republic, Hungary, Italy, Macedonia, The Former Yugoslav Republic of, Portugal
Sunstar Americas

Terminated

Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites

Dental Implants | Alveolar Ridge Preservation

United States
John Kempen

Completed

Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study

Non-infectious, Non-necrotizing Anterior Scleritis

United States
Erydel

Completed

EryDex Pharmacokinetics in Healthy Volunteers (EryDex)

Healthy

United States
Aciont Inc
National Eye Institute (NEI)

Completed

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Non-Infectious Anterior Uveitis

United States
Postgraduate Institute of Dental Sciences Rohtak

Unknown

Effect of Simvastatin as Pulpotomy Agent in Cariously Exposed Permanent Molars

Reversible Pulpitis

India
Queen's University

Completed

A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy

Colonoscopy

Canada
US Department of Veterans Affairs

Completed

Safety and Efficacy of Routine Colonoscopy Preparations

Spinal Cord Injury

United States
University of Southern California

Not yet recruiting

Late Preterm Corticosteroids and Neonatal Hypoglycemia

Prematurity | Neonatal Hypoglycemia

United States
AVM Biotechnology Inc
Medpace, Inc.

Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies (OPAL)

Lymphoid Malignancies

United States
Muhimbili University of Health and Allied Sciences
Karolinska Institutet; Uppsala University; The University of Western Australia

Completed

"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania" (ALU-PQ)

Malaria,Falciparum

Tanzania
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)

Type 2 Diabetes Mellitus
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Tel-Aviv Sourasky Medical Center

Unknown

Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)

Scars | Keloid | Hypertrophic Scar | Scarring
HonorHealth Research Institute
University of Arizona; Agenus Inc.; Translational Genomics Research Institute

Not yet recruiting

The Seven Trial: Exploiting the Unfolded Protein Response

Pancreatic Cancer Metastatic | Pancreatic Adenocarcinoma Metastatic

United States
National Institute of Allergy and Infectious Diseases...

Completed

Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...

Malaria

Mali
Herning Hospital
Hospital of Southern Jutland

Recruiting

Dexamethasone and Robotic-assisted Hysterectomy

Pain, Postoperative | Inflammatory Response | Sexual Behavior | Nausea, Postoperative | Incontinence

Denmark
University of Oslo

Terminated

Mandibular Furcation II Regeneration (FURC-II-REGEN)

Periodontal Diseases | Furcation Defects

Norway
Cairo University

Unknown

Chronic Non Bacterial Prostatitis: a Trial of TRUS Guided Injection of Betamethason

Chronic Non Bacterial Prostatitis
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)

Type 2 Diabetes
Merck Sharp & Dohme LLC

Completed

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Renal Insufficiency | Hemodialysis
Unity Health Toronto
Canadian Institutes of Health Research (CIHR)

Completed

Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET) (TARGET)

End-stage Renal Disease

Canada
National Cancer Institute (NCI)

Completed

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Philadelphia Chromosome Negative Chronic Myelogenous... and other conditions

United States
Ministry of Health, Bahrain

Terminated

Remineralization Agents for the Treatment of White Spot Lesions

White Spot Lesion of Tooth

Bahrain
Edward Kasaraskis

Completed

Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE Study (TRANSLATE)

Familial Amyotrophic Lateral Sclerosis

United States
M.D. Anderson Cancer Center

Completed

CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)

Leukemia | Advanced Cancers

United States

Search clinical trials for: motesanib diphosphate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations